Annette Snejbjerg Bartels
Bioanalytiker
LUKKET: Molecular and Cellular Pharmacology
Jagtvej 160, København Ø
1 - 1 ud af 1Pr. side: 10
- 2012
- Udgivet
TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients
Hertel, P. B., Tu, D., Ejlertsen, Bent Laursen, Jensen, M. R., Balslev, E., Jiang, S., O'Malley, F. P., Pritchard, K. I., Shepherd, L. E., Bartels, Annette Snejbjerg, Brunner, N. & Nielsen, T. O., 2012, I: Breast Cancer Research and Treatment. 132, 1, s. 225-234 10 s.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
ID: 6090964
Flest downloads
-
865
downloads
TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet -
850
downloads
High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet -
687
downloads
Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet